Still hungry on Wegovy? Here's why appetite doesn't always drop straight away

Is it normal to still feel hungry in the first weeks on Wegovy?

Yes, and it catches a lot of people off guard. Wegovy works by activating GLP-1 receptors in the gut and brain, slowing gastric emptying and signalling fullness, but that effect scales with dose. The titration schedule starts at 0.25mg, then 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg (or 7.2mg with the higher-dose pen), with roughly four weeks at each step. If you're wondering whether still feeling hungry on the 0.25mg dose is normal, the short answer is yes, and many people notice only a modest reduction in appetite at this stage, sometimes none at all.

That's by design. The NHS medicines information for semaglutide explains that dose titration exists to reduce side effects, particularly gastrointestinal ones, not to delay efficacy. The fuller appetite suppression typically arrives once you're closer to the maintenance dose. So if you're on your second or third pen and still thinking about lunch at 10am, that's not a treatment failure, it's where you are in the schedule.

One thing our prescribers hear regularly: people assume the hunger should vanish immediately, like flipping a switch. It rarely works that way. Give the titration time to do its job.

Could what you're eating be keeping hunger going?

Semaglutide changes how full you feel, but it doesn't override every signal your body sends. Ultra-processed foods, heavily refined carbohydrates and sugary drinks are digested quickly and tend to leave you hungry again within a couple of hours, regardless of what your GLP-1 receptors are doing. If your meals are still built around foods that spike and crash blood sugar fast, persistent hunger is the predictable result.

Protein and fibre work differently. They slow digestion, support satiety hormones and tend to complement Wegovy's mechanism rather than work against it. A lunch of chicken, lentils and vegetables will sit very differently in your stomach than the same calories from white bread and crisps. The NHS Better Health programme has practical guidance on building meals that support weight management, worth reading alongside your treatment. For more detail on building an eating pattern that works with semaglutide, the guide to what to eat on Wegovy covers this in depth.

Hydration is also worth checking. Thirst is often misread as hunger, and people on GLP-1 medicines sometimes drink less because appetite generally is quieter, so they forget water too.

What if the hunger is emotional or habitual rather than physical?

This is a question worth sitting with honestly. GLP-1 medicines are effective at reducing physical, physiological hunger, the kind driven by ghrelin, gastric signalling and blood sugar. They do much less for the hunger that arrives when you're bored, stressed, anxious or when it's just always been your habit to have a biscuit with the four o'clock cup of tea.

That kind of eating isn't a character flaw; it's deeply ingrained behaviour, often tied to comfort and routine. Wegovy won't retrain those patterns on its own. Many people find that as physical hunger quietens, habitual eating becomes more visible and easier to address, but it can also become more frustrating when it's clearly not about being hungry. Keeping a simple food and mood diary for a couple of weeks can make it easier to spot which hunger is which. If emotional eating is a significant pattern for you, speaking to a GP or a registered dietitian alongside your treatment is a sensible step.

Our full Wegovy information page explains how the medicine works, what the clinical evidence shows, and how a private prescription route compares to NHS access.

When should persistent hunger prompt a conversation with your prescriber?

If you're at the full maintenance dose (2.4mg weekly, or 7.2mg with the higher-dose pen if that's been clinically agreed) and you're still experiencing significant hunger several weeks in, that's worth raising. A prescriber will want to understand whether the dose is being absorbed properly, whether there are dietary factors worth addressing, or whether a different approach makes sense for you.

The STEP 1 trial, published in the New England Journal of Medicine, reported an average weight reduction of around 15% over 68 weeks at the 2.4mg dose, but results varied across participants. Some people respond more to the medicine than others, and dose, diet and lifestyle all interact. Persistent hunger at maintenance is one of the signs that a clinical review is warranted rather than simply waiting it out. If you have moved through the early doses and are curious about why hunger can persist at the 0.5mg stage, that page goes into the detail of what's happening at that point in the titration.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's dispensed, not auto-renewed. If something isn't working as expected, that review is the right place to raise it. You can also check our FAQs for answers to common questions about treatment, or read more about why hunger persists on Wegovy in more detail. For questions about cost, our Wegovy pricing page covers what's included in a private prescription through us.

If you're ready to start (or to discuss whether Wegovy is suitable for you) start your free consultation and a prescriber will review your answers the same day.